
An overview of women’s health in 2024
Betsy Goodfellow | April 9, 2024 | Feature | | Reproductive health, abortion, fertility, reproductive health, women's health
Betsy Goodfellow from Pharmafocus considers the current landscape of women’s health, covering recent debates and ongoing issues within the reproductive health sphere
It has been an extremely interesting few months, if not years, in the field of women’s health as many areas of the specialism have been up for debate, from additional legislation regarding menopause to abortion rights and fertility discussions. There have also been various developments in this area of healthcare, from the opening of new facilities to new treatments and increased access to certain medications.
Read more at: https://www.pharmafocus.com/collections/pharmafocus-april-2024/an-overview-of-women-s-health-in-2024

Related Content

Universal Quantum partners with Open Quantum Institute to tackle endometriosis with new technology
Based in Brighton, UK, Universal Quantum has joined the Open Quantum Institute (OQI) to explore …

Ferring strengthens evidence for flexible dosing of follitropin delta in IVF
Ferring Pharmaceuticals has reported that a conventional 15µg/day starting dose of follitropin delta (Rekovelle) provides …

Theramex receives recommendation for YSELTY in Scotland
Theramex, a dedicated women’s health company, have announced that the Scottish Medicines Consortium (SMC) have …






